{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:49:59Z","timestamp":1762422599855,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.anpede.2021.02.016","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T07:36:54Z","timestamp":1651563414000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"96","author":[{"given":"V\u00edctor","family":"Gal\u00e1n G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"de la Fuente Rega\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Rodr\u00edguez Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"D\u00edaz de Heredia Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gonz\u00e1lez Vicent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Badell Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mar\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Isabel Pascual Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mar\u00eda P\u00e9rez Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"L\u00f3pez Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Soledad Maldonado Regalado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.anpede.2021.02.016_bib0005","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMsr1804754","article-title":"The major causes of death in children and adolescents in the United States","volume":"379","author":"Cunningham","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anpede.2021.02.016_bib0010","first-page":"229","article-title":"Progress and prospects in pediatric leukemia","volume":"46","author":"Madhusoodhan","year":"2016","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"9881","key":"10.1016\/j.anpede.2021.02.016_bib0015","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.anpede.2021.02.016_bib0020","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anpede.2021.02.016_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"35","author":"Kang","year":"2016","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.anpede.2021.02.016_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fonc.2014.00054","article-title":"Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"4","author":"Bernt","year":"2014","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.anpede.2021.02.016_bib0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Aric\u00f2","year":"2000","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.anpede.2021.02.016_bib0040","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","article-title":"Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005","volume":"28","author":"Aric\u00f2","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.anpede.2021.02.016_bib0045","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study","volume":"13","author":"Biondi","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.anpede.2021.02.016_bib0050","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children\u2019s Oncology Group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.anpede.2021.02.016_bib0055","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bjh.13896","article-title":"Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence","volume":"172","author":"Bleckmann","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.anpede.2021.02.016_bib0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.anpede.2021.02.016_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/pbc.22484","article-title":"Imatinib mesylate in children and adolescents with cancer","volume":"55","author":"Barr","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.anpede.2021.02.016_bib0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrclinonc.2016.41","article-title":"Immunological off-target effects of imatinib","volume":"13","author":"Zitvogel","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.anpede.2021.02.016_bib0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2011.08783.x","volume":"154","author":"Rives","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.anpede.2021.02.016_bib0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bjh.12373","volume":"162","author":"Rives","year":"2013","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.anpede.2021.02.016_bib0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2013-09-529008","article-title":"UKALLXII\/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia","volume":"123","author":"Fielding","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anpede.2021.02.016_bib0090","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cam4.383","article-title":"Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia\/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04","volume":"4","author":"Manabe","year":"2015","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.anpede.2021.02.016_bib0095","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.leu.2403001","article-title":"Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children\u2019s Oncology Group study","volume":"17","author":"Borowitz","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.anpede.2021.02.016_bib0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/leu.2012.231","article-title":"Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"27","author":"Denys","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.anpede.2021.02.016_bib0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","article-title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","volume":"129","author":"Theunissen","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anpede.2021.02.016_bib0110","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbmt.2018.12.007","article-title":"Allogeneic hematopoietic stem cell transplantation, especially haploidentical, may improve long-term survival for high-risk pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era","volume":"25","author":"Xue","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.anpede.2021.02.016_bib0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12185-015-1785-1","article-title":"State-of-the-art acute and chronic GVHD treatment","volume":"101","author":"Jamil","year":"2015","journal-title":"Int J Hematol"},{"issue":"11","key":"10.1016\/j.anpede.2021.02.016_bib0120","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"31","key":"10.1016\/j.anpede.2021.02.016_bib0125","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children\u2019s oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.anpede.2021.02.016_bib0130","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3026(18)30173-X","article-title":"Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial","volume":"5","author":"Biondi","year":"2018","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.anpede.2021.02.016_bib0135","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbmt.2011.10.015","article-title":"Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)","volume":"18","author":"Fagioli","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.anpede.2021.02.016_bib0140","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/pbc.22263","article-title":"Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)","volume":"53","author":"Burke","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.anpede.2021.02.016_bib0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003\u20132007 versus 2013\u20132017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.anpede.2021.02.016_bib0150","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/cas.14167","article-title":"Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"110","author":"Akahoshi","year":"2019","journal-title":"Cancer Science"},{"issue":"1","key":"10.1016\/j.anpede.2021.02.016_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.25661","article-title":"Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)","volume":"95","author":"P\u00e9rez-Mart\u00ednez","year":"2020","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.anpede.2021.02.016_bib0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbmt.2005.12.036","article-title":"Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan\/cyclophosphamide regimen","volume":"12","author":"Deeg","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.anpede.2021.02.016_bib0165","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"Walker","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.anpede.2021.02.016_bib0170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2018.11.003","article-title":"Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: an analysis by the Acute Leukemia Working Party of the EBMT","volume":"106","author":"Giebel","year":"2019","journal-title":"Eur J Cancer"},{"issue":"35","key":"10.1016\/j.anpede.2021.02.016_bib0175","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1200\/JCO.2014.56.2223","article-title":"Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation","volume":"32","author":"Willard","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.anpede.2021.02.016_bib0180","doi-asserted-by":"crossref","first-page":"e28079","DOI":"10.1002\/pbc.28079","article-title":"The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Friend","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.anpede.2021.02.016_bib0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5045\/br.2019.54.1.45","article-title":"Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission","volume":"54","author":"Shin","year":"2019","journal-title":"Blood Res"},{"issue":"6","key":"10.1016\/j.anpede.2021.02.016_bib0190","first-page":"490","article-title":"[Safety and efficacy of CD19-targeted CAR-T cells in 14 patients with refractory\/relapsed Philadelphia chromosome-positive acute B-precursor lymphoblastic leukemia]","volume":"41","author":"He","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.anpede.2021.02.016_bib0195","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/10428194.2017.1390237","article-title":"Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells","volume":"59","author":"Geyer","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"10.1016\/j.anpede.2021.02.016_bib0200","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/CM9.0000000000000962","article-title":"A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia","volume":"133","author":"Li","year":"2020","journal-title":"Chin Med J"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:45:00Z","timestamp":1762422300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287922000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2341287922000771"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2021.02.016","relation":{},"ISSN":["2341-2879"],"issn-type":[{"type":"print","value":"2341-2879"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2021.02.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}